Osr Holdings Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.14

-0.02 (-10.71%)

As of Nov 11, 10:18 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target +2,585.7% upside

Low Target $2.62

Average Target $3.76

High Target $5.13

Current Price $0.14

Current
$0.14

Target
$3.76

$2.62 $3.76 avg $5.13

Scenario Analysis

Bear Case

$2.62

1,771.4%

Low target

Base Case

$3.76

+2,585.7%

Avg target

Bull Case

$5.13

+3,564.3%

High target

Risk/Reward

2.0x

Favorable

Price in Context

52-Week High

$0.90

-84.4% from high

52-Week Low

$0.08

+86.7% from low

Target vs 52W High

$3.76

+317.8% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	-12.5%
AMGN Amgen Inc	Hold	42	43%	$190.87	-59.1%
GILD Gilead Sciences Inc	Strong Buy	36	83%	$362.68	+115.9%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	82%	$438.34	-19.2%
MRNA Moderna Inc	Hold	31	32%	$149.45	-35.4%
REGN Regeneron Pharmaceuticals	Buy	36	72%	$76.80	-91.9%
NTRA Natera Inc	Strong Buy	31	90%	$142.91	-55.7%
RVMD Revolution Medicines Inc	Strong Buy	31	94%	$114.11	-35.3%